Amundi
IMVT icon

Amundi’s Immunovant IMVT Stock Holding History

Amundi’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.73M Buy
70,948
+4,100
+6% +$125K ﹤0.01% 1110
2026
Q1 		$1.66M Sell
66,848
-556
-0.8% -$14.4K ﹤0.01% 1149
2025
Q4 		$1.71M Buy
+67,404
New +$1.5M ﹤0.01% 1190
2025
Q2 		– Sell
-2,593
Closed -$40.9K – 1908
2025
Q1 		$40.9K Hold
2,593
– – ﹤0.01% 1828
2024
Q4 		$61.3K Hold
2,593
– – ﹤0.01% 1833
2024
Q3 		$76.8K Sell
2,593
-621
-19% -$18.3K ﹤0.01% 1802
2024
Q2 		$84.2K Hold
3,214
– – ﹤0.01% 1726
2024
Q1 		$91K Hold
3,214
– – ﹤0.01% 1779
2023
Q4 		$141K Sell
3,214
-402
-11% -$14.8K ﹤0.01% 1711
2023
Q3 		$135K Hold
3,616
– – ﹤0.01% 1697
2023
Q2 		$67.8K Hold
3,616
– – ﹤0.01% 1854
2023
Q1 		$51.9K Hold
3,616
– – ﹤0.01% 1880
2022
Q4 		$63.8K Buy
+3,616
New +$45.5K ﹤0.01% 1667

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Amundi's IMVT Position: Q2 2026 in Review

Amundi increased its Immunovant (IMVT) stake by 6.1% in Q2 2026, buying an estimated $125K and bringing the position to 70,948 shares worth $2.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1110.

Amundi first reported a position in IMVT in Q4 2022 and has held it in 13 quarters since. 227 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Amundi held 70,948 shares of Immunovant worth $2.73M as of Q2 2026.
  • Amundi bought 4,100 Immunovant shares in Q2 2026, an estimated $125K.
  • Immunovant made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1110 holding.
  • Amundi first reported a position in Immunovant in Q4 2022 and has held it in 13 quarters since.
  • 227 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.